Manipal Health Shares List at 11% Premium: Investors Book Gains on Market Debut
Source: Mint Markets
Arth Insight · What this means for your wallet
- Manipal Health listed at an 11% premium over its IPO price.
- The stock opened at ₹655 on the BSE and ₹652 on the NSE.
- Investors who were allotted shares have seen immediate value appreciation.
Wealth-Impact Simulator
See what a one-time investment could grow to.
Indicative estimate for education only — not investment advice.
Explore investmentsManipal Health made a positive debut on the stock exchanges today, listing at a premium of over 11% against its issue price. The shares opened at ₹652 on the NSE and ₹655 on the BSE, rewarding successful allottees with immediate listing gains.
- ▸Manipal Health listed at an 11% premium over its IPO price.
- ▸The stock opened at ₹655 on the BSE and ₹652 on the NSE.
- ▸Investors who were allotted shares have seen immediate value appreciation.
- ▸The positive debut reflects strong investor confidence in the healthcare sector.
- ✓Manipal Health listed at an 11% premium over its IPO price.
- ✓The stock opened at ₹655 on the BSE and ₹652 on the NSE.
- ✓Investors who were allotted shares have seen immediate value appreciation.
- ✓The positive debut reflects strong investor confidence in the healthcare sector.
Manipal Health shares made a strong entry into the secondary market today, listing at a premium of more than 11% over the initial public offering (IPO) price. The stock debuted at ₹652 on the National Stock Exchange (NSE) and ₹655 on the BSE, providing a healthy start for retail and institutional investors who were allotted shares in the public issue.
Listing Performance and Market Reaction
The listing price reflects a positive sentiment surrounding the healthcare provider's growth prospects. By opening at ₹655 on the BSE, the stock surpassed the upper end of its IPO price band, signaling robust demand. This double-digit gain is a significant outcome for short-term investors looking for listing-day profits, especially amidst the current market volatility.
What This Means for Retail Investors
For retail investors who participated in the IPO, the 11% premium offers a choice between booking partial profits or holding the stock for long-term gains. Market analysts suggest that while the listing is positive, investors should monitor the company's quarterly performance and expansion plans in the competitive Indian healthcare sector before making further moves.
Company Profile and IPO Context
Manipal Health is one of India's leading multi-specialty healthcare providers. The successful listing follows an IPO process that saw healthy subscription levels across different investor categories. The funds raised through the issue are expected to be utilized for debt repayment, capital expenditure, and general corporate purposes, which could further strengthen the company's balance sheet in the coming years.
- NSE Listing Price: ₹652
- BSE Listing Price: ₹655
- Listing Gain: Over 11%
As the stock begins its journey as a publicly traded entity, its performance will be closely watched by the broader BFSI sector and healthcare industry peers. Investors are advised to consult with financial experts to align their holdings with their individual risk profiles.
This report is for informational purposes only and does not constitute financial or investment advice.
Community Pulse · This story
How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What was the listing price of Manipal Health on the NSE?
Manipal Health shares listed at ₹652 on the National Stock Exchange (NSE).
How much profit did investors make on the listing day?
Investors who were allotted shares in the IPO saw a listing gain of more than 11% based on the opening prices.
Should I sell or hold Manipal Health shares after listing?
This depends on your investment horizon. Short-term investors may consider booking profits, while long-term investors should evaluate the company's fundamentals and future growth.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
IPOBreakingH.R. Hygiene Products IPO Lists Today on BSE SME; Modest Listing Gain Expected
H.R. Hygiene Products makes its debut on the BSE SME platform today, following an IPO that was subscribed 6.26 times. The grey market premium (GMP) suggests a small listing gain of around 1% over the upper issue price of ₹88.
IPOBreakingMolbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Molbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
BreakingIRDAI Directs Insurers to Fast-Track Assam Flood Claims; Special Desks, Helplines Setup
India's insurance regulator, IRDAI, has instructed all insurance companies to expedite the settlement of flood claims for policyholders affected by the recent deluge in Assam. This directive mandates immediate deployment of surveyors, establishment of dedicated district-level claims desks, and 24x7 helplines to streamline the process. The move follows extensive flooding and heavy rainfall across Assam, which began on July 19.
Related Stories
IPOBreakingH.R. Hygiene Products IPO Lists Today on BSE SME; Modest Listing Gain Expected
H.R. Hygiene Products makes its debut on the BSE SME platform today, following an IPO that was subscribed 6.26 times. The grey market premium (GMP) suggests a small listing gain of around 1% over the upper issue price of ₹88.
IPOBreakingMolbio Diagnostics IPO: Price Band ₹768-₹807, Opens Aug 10
Molbio Diagnostics has announced its Initial Public Offering (IPO) with a price band set between ₹768 and ₹807 per share. The subscription period will be open from August 10 to August 12.
BreakingIRDAI Directs Insurers to Fast-Track Assam Flood Claims; Special Desks, Helplines Setup
India's insurance regulator, IRDAI, has instructed all insurance companies to expedite the settlement of flood claims for policyholders affected by the recent deluge in Assam. This directive mandates immediate deployment of surveyors, establishment of dedicated district-level claims desks, and 24x7 helplines to streamline the process. The move follows extensive flooding and heavy rainfall across Assam, which began on July 19.
BreakingIndian Microfinance Loans Dip 4% to ₹3.26 Lakh Crore by June End Amidst Monsoon Concerns
India's microfinance sector saw its loan portfolio contract by 4% to ₹3.26 lakh crore by the end of June. This first-quarter decline is primarily due to an uneven monsoon season, which has dampened rural demand and increased caution among lenders.